Clinical trial
A Non-interventional Study on the Epidemiology and Testing of HER2 in Breast Cancer in Germany
NCT02666261 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Non-interventional Study on the Epidemiology and Testing of HER2 in Breast Cancer in Germany
- Lead sponsor
- Hoffmann-La Roche
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 4, 2016
- Completion date
- February 28, 2018
- Enrollment
- 15,000 (estimated)
- Sites
- 64
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer